Designing Antibodies with AI

Surge Biswas is the cofounder and CEO of Nabla Bio, an AI platform to enable precise drug design and high-throughput measurement of drug properties. They recently raised $26M Series A led by Radical Ventures. He has a PhD in Bioinformatics and Integrative Genomics from Harvard University. Surge's favorite book: Permutation City (Author: Greg Egan)(00:01) Introduction(00:07) Generative AI in Drug Design(01:19) Traditional vs. AI-driven Drug Discovery(03:42) Designing Antibodies(05:06) Therapeu...